The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The RIST design: A molecularly targeted multimodal approach for the treatment of patients with relapsed and refractory neuroblastoma.
Selim Corbacioglu
No relevant relationships to disclose
Daniel Steinbach
No relevant relationships to disclose
Holger N. Lode
No relevant relationships to disclose
Bernd Gruhn
No relevant relationships to disclose
Michael Fruehwald
No relevant relationships to disclose
Mechthild Broeckelmann
No relevant relationships to disclose
Meinolf Suttorp
No relevant relationships to disclose
Gabriele Escherich
No relevant relationships to disclose
Gunnar Cario
No relevant relationships to disclose
Karoline Ehlert
No relevant relationships to disclose
Bernhard Meister
No relevant relationships to disclose
Thorsten Simon
No relevant relationships to disclose
Klaus-Michael Debatin
No relevant relationships to disclose
Michaela Kuhlen
No relevant relationships to disclose
Isa Feddersen
No relevant relationships to disclose